Munehisa Kito

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Postmenopausal Women

Stem Cell Transplantation

Top Venues

Bioengineering (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kaoru Aoki, Hirokazu Ideta, Yukiko Komatsu, Atsushi Tanaka, Munehisa Kito, Masanori Okamoto, Jun Takahashi, Shuichiro Suzuki, Naoto Saito
Bone-Regeneration Therapy Using Biodegradable Scaffolds: Calcium Phosphate Bioceramics and Biodegradable Polymers. Bioengineering (Basel, Switzerland) 11 (2) (2024)
Kaoru Aoki, Hirokazu Ideta, Yukiko Komatsu, Atsushi Tanaka, Munehisa Kito, Masanori Okamoto, Jun Takahashi, Shuichiro Suzuki, Naoto Saito
Bone-Regeneration Therapy Using Biodegradable Scaffolds: Calcium Phosphate Bioceramics and Biodegradable Polymers. Bioengineering (Basel, Switzerland) 11 (2) (2024)
Kaoru Aoki, Hirokazu Ideta, Yukiko Komatsu, Atsushi Tanaka, Munehisa Kito, Masanori Okamoto, Jun Takahashi, Shuichiro Suzuki, Naoto Saito
Bone-Regeneration Therapy Using Biodegradable Scaffolds: Calcium Phosphate Bioceramics and Biodegradable Polymers. Bioengineering (Basel, Switzerland) 11 (2) (2024)
Munehisa Kito, Keisuke Ae, Masanori Okamoto, Makoto Endo, Kunihiro Ikuta, Akihiko Takeuchi, Naohiro Yasuda, Taketoshi Yasuda, Yoshinori Imura, Takeshi Morii, Kazutaka Kikuta, Teruya Kawamoto, Yutaka Nezu, Ichiro Baba, Shusa Ohshika, Takeshi Uehara, Takafumi Ueda, Jun Takahashi, Hirotaka Kawano
Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. Cancers 15 (8) (2023)
Munehisa Kito, Keisuke Ae, Masanori Okamoto, Makoto Endo, Kunihiro Ikuta, Akihiko Takeuchi, Naohiro Yasuda, Taketoshi Yasuda, Yoshinori Imura, Takeshi Morii, Kazutaka Kikuta, Teruya Kawamoto, Yutaka Nezu, Ichiro Baba, Shusa Ohshika, Takeshi Uehara, Takafumi Ueda, Jun Takahashi, Hirotaka Kawano
Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group. Cancers 15 (8) (2023)